Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity

Hippocampus

Volumn 13, Issue 7, 2003, Pages 826-834

  Avital, Avi ^a   Goshen, Inbal ^b   Kamsler, Ariel ^c   Segal, Menahem ^c   Iverfeldt, Kerstin ^d   Richter Levin, Gal ^a   Yirmiya, Raz ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Fear conditioning; IL 1 receptor knockout; Long term potentiation (LTP); Paired pulse stimulation; Water maze

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONDITIONING; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; LEARNING; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MENTAL TASK; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE;

ANIMALS; CONDITIONING (PSYCHOLOGY); ELECTRIC STIMULATION; FEAR; HIPPOCAMPUS; INTERLEUKIN-1; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; NEURAL INHIBITION; NEURONAL PLASTICITY; REACTION TIME; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; SIGNAL TRANSDUCTION;

EID: 0142172107     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.10135     Document Type: Article

References (52)

1. + neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol 136:44-52.
2. Aubert A, Vega C, Dantzer R, Goodall G. 1995. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun 9:129-148.
3. Bellinger FP, Madamba S, Siggins GR. 1993. Interleukin-1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234.
4. Besedovsky HO, del-Rey A. 1996. Immune-neuroendocrine interactions: facts and hypotheses. Endocr Rev 17:64-102.
5. Bliss TVP, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
6. Carrie A, Jun L, Bienvenu T, Vinet M, McDonell N, Couvert P, Zemni R, Cardona A, Van Buggenhout G, Frints S, Hamel B, Moraine C, Ropers HH, Storm T, Howell GR, Whittaker A, Ross MT, Kahn A, Fryns J, Beldjord C, Marynen P, Chelly J. 1999. A new member of the IL-1 Receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nature genet 23:25-31.
7. Conrad CD, Lupien SJ, McEwen BS. 1999. Support for a bimodal role for type II adrenal steroid receptors in spatial memory. Neurobiol Learn Mem 72:39-46.
8. Coogan AN, O'Leary DM, O'Connor JJ. 1999a. P42/44 MAP kinase inhibitor PD98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. J Neurophysiol 81: 103-110.
9. Coogan AN, O'Neill LA, O'Connor JJ. 1999b. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1 beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93:57-69.
10. Cunningham AJ, Murray CA, O'Neill LAJ, Lynch MA, O'Connor JJ. 1996. Interleukin-1β (IL-1β) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20.
11. Dantzer R. 2001. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15:7-24.
12. De los Santos MJ, Mercader A, Frances A, Portoles E, Remohi J, Pellicer A, Simon C. 1996. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol Reprod 54:563-574.
13. Diamond DM, Bennet MC, Fleshner M, Rose GM. 1992. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 2:421-430.
14. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
15. Fanselow MS. 2000. Contexual fear, gestalt memories and the hippocampus. Behav Brain Res 110:73-81.
16. Gadient RA, Cron KC, Otten U. 1990. Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 117:335-340.
17. Gibertini M, Newton C, Friedman H, Klein TW. 1995. Spatial learning in mice infected with Legionella pneumophila or administered exogenous interleukin-1β. Brain Behav Immun 9:113-128.
18. Goshen I, Avital A, Kamsler A, Winocur G, Iverfeldt K, Segal M, Richter-Levin G, Yirmiya R. 2002. The role of interleukin-1 in hippocampal dependent memory processes and neural plasticity. Brain Behav Immun 16:185-186.
19. Holscher C, McGlinchey L, Anwyl R, Rowan MJ. 1996. 7-Nitroindazole a selective neuronal nitric oxide synthase inhibitor in vivo impairs spatial learning in the rat. Learn Mem 2:267-278.
20. Hu XL, Yang Y, Hunt JS. 1992. Differential distribution of interleukin-1 alpha and interleukin-1 beta proteins in human placentas. J Reprod Immunol 22:257-268.
21. Huwiler A, Pfeilschifter J. 1994. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett 350:135-138.
22. Ishida K, Yoshimura N, Yoshida M, Honda Y, Murase K, Hayashi K. 1997. Expression of neurotrophic factors in cultured human retinal pigment epithelial cells. Curr Eye Res 16:96-101.
23. Jin H, Gardner RJ Viswesvaraiah R, Muntoni F, Roberts RG. 2000. Two novel members of the interleuhin-1 receptor gene family one deleted in Xp22.1-Xp21.3 mental retardation. Eur J Hum Genet 8:87-9.
24. Kamiguchi H, Yoshida K, Sasaki H, Inaba M, Wakamoto H, Otani M, Toya S. 1995. Release of ciliary neurotrophic factor from cultured astrocytes and its modulation by cytokines. Neurochem Res 20:1187-1193.
25. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323-326.
26. Kelly A, Conory S, Lynch MA. 1998. Evidence that nerve growth factor plays a role in long-term potentiation in the rat dentate gyrus. Neuropharmacology 37:561-570.
27. Kumon Y, Sakaki S, Watanabe H, Nakao K, Ohta S, Matsuda S, Yoshimura H, Sakanaka M. 1996. Ciliary neurotrophic factor attenuates spatial cognition impairment cortical infraction and thalamic degeneration in spontaneously hypertensive rats with focal cerebral ischemia. Neurosci Lett 206:141-144.
28. Labow M, Shuster D, Zetterstorm M, Nunes P, Terry R, Cullinan EB, Bartfei T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor deficient mice. J Immunol 159:2452-2461.
29. Lee SC, Dickson DW, Brosnan CF. 1995. Interleukin-1 nitric oxide and reactive astrocytes. Brain Behav Immun 9:345-354.
30. Ling ZD, Potter ED, Lipton JW, Carvey PM. 1998. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149:411-423.
31. Loddick SA, Liu C, Takao T, Hashimoto K, De Souza EB. 1998. Interleukin-1 receptors: cloning studies and role in central nervous system disorders. Brain Res Rev 26:306-319.
32. Lu YF, Kandel ER, Hawkins RD. 1999. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 19:10250-10261.
33. Maren S. 2001. Neurobiology of pavlovian fear conditioning. Annu Rev Neurosci 24:897-931.
34. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J. 1982. Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683.
35. Mrak RE, Griffin WS. 2000. Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 59:471-476.
36. Murray CA, Lynch MA. 1998. Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age-and stress-induced impairments in long-term potentiation. J Neurosci 18:2974-2981.
37. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS. 2000. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-368.
38. O'Connor JJ, Coogan AN. 1999. Action of the pro-inflammatory cytokine IL-1β on central synaptic transmission. Exp Physiol 84:601-614.
39. Oitzl MS, van Oers H, Schobitz B, de Kloet ER. 1993. Interleukin-1β but not interleukin-6 impairs spatial navigation learning. Brain Res 613: 160-163.
40. Potter ED, Ling ZD, Carvey PM. 1999, Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 296:235-246.
41. Pugh CR, Fleshner M, Watkins LR, Maier SF, Rudy JW. 2001 The immune system and memory consolidation: a role for the cytokine IL-1β. Neurosci Biobehav Rev 25:29-41.
42. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Pollmacher T. 2001. Endotoxin-induced emotional and cognitive disturbances in healthy volunteers are associated with increased plasma levels of cytokines and cortisol. Arch Gen Psychiatry 58:445-452.
43. Rothwell NJ, Luheshi GN. 2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23:618-625.
44. Schneider H, Pitossi F, Balschun D, Wagner A, Del Rey A, Besedovsky HO. 1998. A neuromodulatory role of interleukin-1 in the hippocampus. Proc Natl Acad Sci U S A 95:7778-7783.
45. Selcher JC, Atkins CM, Trzaskos JM, Paylor R, Sweatt JD. 1999. A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem 6:478-490.
46. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, Sims JE. 2000. Four new members expand the interleukin-1 superfamily. J Biol Chem 275:1169-1175.
47. Tulving E, Markowitsch HJ 1998. Episodic and declarative memory: role of the hippocampus. Hippocampus 8:198-204.
48. Vereker E, O'Donnell E, Lynch MA. 2000. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 20:6811-6819.
49. Xie CW, Sayan D, Chen QS, Wei WZ, Smith D, Liu X. 2000. Deficient long-term memory and long-lasting long-term potentiation in mice with a targeted deletion of neurotrophin-4 gene. Proc Natl Acad Sci U S A 97:8816-8821.
50. Yasuhara O, Matsuo A, Terai K, Walker, DG, Berger AE, Akiguchi I, Kimura J, McGeer PL. 1997. Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathol 93:414-420.
51. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, Shavit Y, Ovadia H, Weidenfeld J, Morag A, Newman ME, Pollmacher T. 2000. Illness cytokines and depression. Ann NY Acad Sci 917:478-487
52. Yirmiya R, Winocur G, Goshen I. 2002. Brain Interleukin-1 (IL-1) is involved in spatial memory and passive avoidance conditioning. Neurobiol Learn Mem 78:379-389.